| |
Welcome to Karolinska Institutet and Aprea |
|
xxxxxxxxx
xxxx |
 |
xxxxxxxxxxxxxxx |
Aprea AB develops target specific drugs for the treatment of cancer with non-functional p53
Postal address: Aprea AB, Karolinska Institutet Science Park, Nobels väg 3, SE-171 65 Solna, Sweden; Org. No.: 556631-2285
|